“Adherence To A Mediterranean Diet And Cognitive Function In The Age-Related Eye Disease Studies 1 & 2.”. Alzheimers Dement 16 (6). Alzheimers Dement: 831-842. doi:10.1002/alz.12077.
. 2020. “Adherence To The Mediterranean Diet And Progression To Late Age-Related Macular Degeneration In The Age-Related Eye Disease Studies 1 And 2.”. Ophthalmology. Ophthalmology. doi:10.1016/j.ophtha.2020.04.030.
. 2020. “Association Of 2-Year Progression Along The Areds Amd Scale And Development Of Late Age-Related Macular Degeneration Or Loss Of Visual Acuity: Areds Report 22.”. Jama Ophthalmol. Jama Ophthalmol. doi:10.1001/jamaophthalmol.2020.0824.
. 2020. “Macular Telangiectasia Type 2: Visual Acuity, Disease End Stage, And The Mactel Area: Mactel Project Report Number 8.”. Ophthalmology. Ophthalmology. doi:10.1016/j.ophtha.2020.03.040.
. 2020. “Retinal Specialist Versus Artificial Intelligence Detection Of Retinal Fluid From Oct: Age-Related Eye Disease Study 2: 10-Year Follow-On Study.”. Ophthalmology. Ophthalmology. doi:10.1016/j.ophtha.2020.06.038.
. 2020. “Visual Acuity Outcomes After Anti-Vascular Endothelial Growth Factor Treatment For Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 19.”. Ophthalmol Retina 4 (1). Ophthalmol Retina: 3-12. doi:10.1016/j.oret.2019.06.001.
. 2020. “The Association Of Aspirin Use With Age-Related Macular Degeneration Progression In The Age-Related Eye Disease Studies: Age-Related Eye Disease Study 2 Report No. 20.”. Ophthalmology 126 (12). Ophthalmology: 1647-1656. doi:10.1016/j.ophtha.2019.06.023.
. 2019. “Association Of Dietary And Supplementary Calcium Intake With Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 39.”. Jama Ophthalmol 137 (5). Jama Ophthalmol: 543-550. doi:10.1001/jamaophthalmol.2019.0292.
. 2019. “Effect Of Ciliary Neurotrophic Factor On Retinal Neurodegeneration In Patients With Macular Telangiectasia Type 2: A Randomized Clinical Trial.”. Ophthalmology 126 (4). Ophthalmology: 540-549. doi:10.1016/j.ophtha.2018.09.041.
. 2019. “Imaging Characteristics Of Choroidal Neovascular Lesions In The Areds2-Home Study: Report Number 4.”. Ophthalmol Retina 3 (4). Ophthalmol Retina: 326-335. doi:10.1016/j.oret.2019.01.004.
. 2019. “Natural History Of Drusenoid Pigment Epithelial Detachment Associated With Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17.”. Ophthalmology 126 (2). Ophthalmology: 261-273. doi:10.1016/j.ophtha.2018.08.017.
. 2019. “No Cfh Or Arms2 Interaction With Omega-3 Fatty Acids, Low Versus High Zinc, Or Β-Carotene Versus Lutein And Zeaxanthin On Progression Of Age-Related Macular Degeneration In The Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No.”. Ophthalmology 126 (11). Ophthalmology: 1541-1548. doi:10.1016/j.ophtha.2019.06.004.
. 2019. “Prevalence, Risk, And Genetic Association Of Reticular Pseudodrusen In Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report 21.”. Ophthalmology 126 (12). Ophthalmology: 1659-1666. doi:10.1016/j.ophtha.2019.07.022.
. 2019. “Abnormal Retinal Reflectivity To Short-Wavelength Light In Type 2 Idiopathic Macular Telangiectasia.”. Retina 38 Suppl 1. Retina: S79-S88. doi:10.1097/IAE.0000000000001728.
. 2018. “Association Of Mortality With Ocular Diseases And Visual Impairment In The Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 13.”. Ophthalmology 125 (4). Ophthalmology: 512-521. doi:10.1016/j.ophtha.2017.10.028.
. 2018. “Characteristics Of Pigmented Lesions In Type 2 Idiopathic Macular Telangiectasia.”. Retina 38 Suppl 1. Retina: S43-S50. doi:10.1097/IAE.0000000000001842.
. 2018. “Correlation Of Clinical And Structural Progression With Visual Acuity Loss In Macular Telangiectasia Type 2: Mactel Project Report No. 6-The Mactel Research Group.”. Retina 38 Suppl 1. Retina: S8-S13. doi:10.1097/IAE.0000000000001697.
. 2018. “Correlation Of Structural And Functional Outcome Measures In A Phase One Trial Of Ciliary Neurotrophic Factor In Type 2 Idiopathic Macular Telangiectasia.”. Retina 38 Suppl 1. Retina: S27-S32. doi:10.1097/IAE.0000000000001706.
. 2018. “A Deep Phenotype Association Study Reveals Specific Phenotype Associations With Genetic Variants In Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 (Areds2) Report No. 14.”. Ophthalmology 125 (4). Ophthalmology: 559-568. doi:10.1016/j.ophtha.2017.09.023.
. 2018. “Genome-Wide Analysis Of Disease Progression In Age-Related Macular Degeneration.”. Hum Mol Genet 27 (5). Hum Mol Genet: 929-940. doi:10.1093/hmg/ddy002.
. 2018. “Longitudinal Correlation Of Ellipsoid Zone Loss And Functional Loss In Macular Telangiectasia Type 2.”. Retina 38 Suppl 1. Retina: S20-S26. doi:10.1097/IAE.0000000000001715.
. 2018. “Potential Effects Of Hormone Therapy In Type 2 Idiopathic Macular Telangiectasia.”. Ophthalmic Res 60 (1). Ophthalmic Res: 38-42. doi:10.1159/000479932.
. 2018. “Treatment Of Geographic Atrophy With Intravitreal Sirolimus: The Age-Related Eye Disease Study 2 Ancillary Study.”. Ophthalmol Retina 2 (5). Ophthalmol Retina: 441-450. doi:10.1016/j.oret.2017.08.015.
. 2018. “Bivariate Analysis Of Age-Related Macular Degeneration Progression Using Genetic Risk Scores.”. Genetics 206 (1). Genetics: 119-133. doi:10.1534/genetics.116.196998.
. 2017. “Optical Coherence Tomography Predictors Of Risk For Progression To Non-Neovascular Atrophic Age-Related Macular Degeneration.”. Ophthalmology 124 (12). Ophthalmology: 1764-1777. doi:10.1016/j.ophtha.2017.06.032.
. 2017.